NPPA issued a notification regarding fixation of retail price of Clonazepam IP 0.5 mg + Paroxetine Hydrochloride Hemihydrate IP eq. to Paroxetine 12.5 mg (As Controlled Release)' for M/s Akums Drugs & Pharmaceuticals Ltd (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

Jul 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 16, 2026, issued a notification regarding fixation of retail price of Clonazepam IP 0.5 mg + Paroxetine Hydrochloride Hemihydrate IP eq. to Paroxetine 12.5 mg (As Controlled Release)' for M/s Akums Drugs & Pharmaceuticals Ltd (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer).

The following has been stated:-

•Each Film Coated Bilayered Tablet Contains: Clonazepam IP 0.5 mg + Paroxetine Hydrochloride Hemihydrate IP eq. to Paroxetine 12.5 mg (As Controlled Release)' for M/s Akums Drugs & Pharmaceuticals Ltd (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer), the retail price is 17.52 Rs.

[Notification No.: 19(5255)/2026/DP/NPPA/Div.III/14668/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT